OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys
Lisa R. Gerak, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 3, pp. 363-371
Closed Access | Times Cited: 6
Lisa R. Gerak, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 3, pp. 363-371
Closed Access | Times Cited: 6
Showing 6 citing articles:
Carfentanil is a β‐arrestin‐biased agonist at the μ opioid receptor
Nokomis Ramos‐Gonzalez, Sam Groom, Katy J. Sutcliffe, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 18, pp. 2341-2360
Open Access | Times Cited: 16
Nokomis Ramos‐Gonzalez, Sam Groom, Katy J. Sutcliffe, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 18, pp. 2341-2360
Open Access | Times Cited: 16
Endogenous opiates and behavior: 2023
Richard J. Bodnar
Peptides (2024) Vol. 179, pp. 171268-171268
Closed Access | Times Cited: 6
Richard J. Bodnar
Peptides (2024) Vol. 179, pp. 171268-171268
Closed Access | Times Cited: 6
Comparison of theμ-Opioid Receptor Antagonists Methocinnamox and Naloxone to Reverse and Prevent the Ventilatory Depressant Effects of Fentanyl, Carfentanil, 3-Methylfentanyl, and Heroin in Male Rats
Takato Hiranita, Nicholas P. Ho, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 1, pp. 4-17
Open Access | Times Cited: 5
Takato Hiranita, Nicholas P. Ho, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 1, pp. 4-17
Open Access | Times Cited: 5
Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys
David R. Maguire, Charles P. France
Neuropharmacology (2023) Vol. 243, pp. 109777-109777
Open Access | Times Cited: 3
David R. Maguire, Charles P. France
Neuropharmacology (2023) Vol. 243, pp. 109777-109777
Open Access | Times Cited: 3
Evaluation of potential punishing effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rhesus monkeys responding under a choice procedure
David R. Maguire
Behavioural Pharmacology (2024) Vol. 35, Iss. 7, pp. 378-385
Closed Access
David R. Maguire
Behavioural Pharmacology (2024) Vol. 35, Iss. 7, pp. 378-385
Closed Access
Methocinnamox is a Potent and Long-Acting Antagonist that can Prevent and Reverse Opioid-Induced Respiratory Depression
James A. Carr, Daniel J Morgan
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 1, pp. 1-3
Closed Access
James A. Carr, Daniel J Morgan
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 1, pp. 1-3
Closed Access
